These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 3917193)
21. VEB-6 extended-spectrum beta-lactamase-producing Proteus mirabilis from Sultanate of Oman. Potron A; Poirel L; Elhag K; Al Yaqoubi F; Nordmann P Int J Antimicrob Agents; 2009 Nov; 34(5):493-4. PubMed ID: 19525094 [No Abstract] [Full Text] [Related]
22. [Serodiagnosis and immunological aspects of Proteus infection. III. Immunological, bacteriological and pathomorphological parallels in experimental Proteus intestinal infections, mono- and mixed]. Bidnenko SI; Bernasovskaia EP; Barshteĭn IuA; Ganziĭ GP Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):105-10. PubMed ID: 6758428 [TBL] [Abstract][Full Text] [Related]
23. [Studies on retrograde Proteus mirabilis pyelonephritis in the rat. I. An experiment to obtain both pathologic sections and total number of bacteria from one kidney simultaneously (author's transl)]. Takamoto H Nihon Hinyokika Gakkai Zasshi; 1981 Aug; 72(8):1006-10. PubMed ID: 7033614 [No Abstract] [Full Text] [Related]
24. [Response to antibiotics of Proteus strains isolated from different types of clinical material]. Ovetchin PV; Tsyganenko AIa Antibiotiki; 1984 Apr; 29(4):272-5. PubMed ID: 6378080 [TBL] [Abstract][Full Text] [Related]
25. Defined mutants of Proteus mirabilis lacking flagella cause ascending urinary tract infection in mice. Legnani-Fajardo C; Zunino P; Piccini C; Allen A; Maskell D Microb Pathog; 1996 Nov; 21(5):395-405. PubMed ID: 8938645 [TBL] [Abstract][Full Text] [Related]
26. [Detection of bacteriocin production by Proteus mirabilis. Proposal for a new protocol for bacteriocin typing]. Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández Crehuet M; Cueto Espinar A; Piédrola Angulo G Rev Latinoam Microbiol; 1984; 26(4):299-303. PubMed ID: 6395246 [No Abstract] [Full Text] [Related]
28. Evaluation of a rat model for induction of pyelonephritis with cell wall deficiency variants of Proteus mirabilis. Hughes BF; Schwarz H; Gomolka D Invest Urol; 1972 Jul; 10(1):10-3. PubMed ID: 4556712 [No Abstract] [Full Text] [Related]
29. [Epidemiological application of a new bacteriocin typing procedure for Proteus mirabilis]. Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández-Crehuet M; Gálvez Vargas R; Piédrola Angulo G Rev Latinoam Microbiol; 1985; 27(1):7-10. PubMed ID: 3892620 [No Abstract] [Full Text] [Related]
30. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients. Saito R; Okugawa S; Kumita W; Sato K; Chida T; Okamura N; Moriya K; Koike K Clin Microbiol Infect; 2007 Dec; 13(12):1204-6. PubMed ID: 17850340 [TBL] [Abstract][Full Text] [Related]
39. [Study of the experimental pathogenic action of Proteus]. Lukach IG; Varshteĭn IuA Mikrobiol Zh; 1974; 36(1):86-9. PubMed ID: 4601302 [No Abstract] [Full Text] [Related]
40. Isolation of Proteus mirabilis from severe neonatal sepsis and central nervous system infection with extensive pneumocephalus. Kassim Z; Aziz AA; Haque QM; Cheung HA Eur J Pediatr; 2003 Sep; 162(9):644-5. PubMed ID: 12836017 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]